Company intelligence / Profile preview

Signum Surgical

Galway, Ireland

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Signum Surgical is developing a minimally invasive, absorbable implant (BioHealx) for the treatment of anal fistula; current communications focus on optimizing healing, reducing recurrence, and preserving continence. The device has demonstrated promise for single-procedure healing but published clinical results are not detailed in public sources

Therapeutic areas: Gastroenterology
Modalities: DeviceBiologic (absorbable implant)
Industry: Implantable Medical Devices

Partnerships

No major pharmaceutical or large biotech partnerships reported in public sources

Beyond the preview

Go deeper on Signum Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signum Surgical.

Explore the full profile